Novel synthesis of nitro-quinoxalinone derivatives as aldose reductase inhibitors

被引:17
|
作者
Hussain, Saghir [1 ]
Parveen, Shagufta [1 ]
Qin, Xiangyu [1 ]
Hao, Xin [1 ]
Zhang, Shuzhen [1 ]
Chen, Xin [1 ]
Zhu, Changjin [1 ]
Ma, Bing [1 ]
机构
[1] Beijing Inst Technol, Dept Appl Chem, Beijing 100081, Peoples R China
基金
高等学校博士学科点专项科研基金; 中国国家自然科学基金;
关键词
Quinoxalinone derivatives; Aldose reductase inhibitors; Structure-activity relationship; DIABETIC COMPLICATIONS; POTENT; RAT; PREVENTION; NEUROPATHY; CATARACT; AGENTS;
D O I
10.1016/j.bmcl.2014.03.053
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel, non-acid series of nitroquinoxalinone derivatives was synthesized and tested for their inhibitory activity against aldose reductase as targeting enzyme. All active compounds displayed an 8-nitro group, and showed significant activity in IC50 values ranging from 1.54 to 18.17 mu M. Among them 6,7-dichloro-5,8-dinitro-3-phenoxyquinoxalin-2(H-1)-one (7e), exhibited the strongest aldose reductase activity with an IC50 value of 1.54 mu M and a good SAR (structure-activity relationship) profile. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2086 / 2089
页数:4
相关论文
共 50 条
  • [21] Benzoxazoline and benzimidazoline derivatives as novel aldose reductase inhibitors, part 2: Lead optimization
    Nakao, K
    Asao, M
    Shirai, H
    Saito, K
    Moriya, T
    Iwata, H
    Matsumoto, M
    Matsuoka, Y
    Shimizu, R
    MEDICINAL CHEMISTRY RESEARCH, 1999, 9 (7-8) : 631 - 642
  • [22] Synthesis of organic nitrates of luteolin as a novel class of potent aldose reductase inhibitors
    Wang, Qi-Qin
    Cheng, Ning
    Zheng, Xiao-Wei
    Peng, Sheng-Ming
    Zou, Xiao-Qing
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (14) : 4301 - 4310
  • [23] Design and synthesis of novel inhibitors of aldose reductase for the treatment of diabetic complications.
    Van Zandt, MC
    Sibley, EO
    Combs, KJ
    McCann, EE
    Flam, B
    Lavoie, DJ
    Sawicki, D
    Sabetta, A
    Carrington, A
    Sredy, J
    Calderone, V
    Cuevrier, B
    Podjarny, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U957 - U957
  • [24] Synthesis and Structure-Activity Relationship Studies of Quinoxaline Derivatives as Aldose Reductase Inhibitors
    Wu, Bobin
    Yang, Yanchun
    Qin, Xiangyu
    Zhang, Shuzhen
    Jing, Chaojun
    Zhu, Changjin
    Ma, Bing
    CHEMMEDCHEM, 2013, 8 (12) : 1913 - 1917
  • [25] Synthesis of benzothiadiazine derivatives exhibiting dual activity as aldose reductase inhibitors and antioxidant agents
    Zhu, Shaojuan
    Hao, Xin
    Zhang, Shuzhen
    Qin, Xiangyu
    Chen, Xin
    Zhu, Changjin
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (12) : 2880 - 2885
  • [26] Synthesis and aldose reductase inhibitory activities of novel N-nitromethylsulfonanilide derivatives
    Inoue, J
    Cui, YS
    Sakai, O
    Nakamura, Y
    Kogiso, H
    Kador, PF
    BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (08) : 2167 - 2173
  • [27] ALDOSE REDUCTASE INHIBITORS
    ARMSTRONG, FM
    HAGAN, KJ
    DIABETES & METABOLISM, 1990, 16 (4BIS): : 413 - 414
  • [28] ALDOSE REDUCTASE INHIBITORS
    KIRCHAIN, WR
    RENDELL, MS
    PHARMACOTHERAPY, 1990, 10 (05): : 326 - 336
  • [29] Aldose reductase inhibitors
    Oka, M
    Kato, N
    JOURNAL OF ENZYME INHIBITION, 2001, 16 (06): : 465 - 473
  • [30] ALDOSE REDUCTASE INHIBITORS
    DVORNIK, D
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1977, 174 (SEP): : 17 - 17